Hercules

Labopharm amends debt facility agreement with Hercules

- Company Improves Financial Flexibility - LAVAL, QC, June 25 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced it has amended its debt facility agreement with Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC ). Based on regulatory approval and rece...

Ashland Completes Acquisition of Hercules

Five commercial units' pro forma revenue exceeds $10 billion COVINGTON, Ky. and WILMINGTON, Del., Nov. 13 /PRNewswire-FirstCall/ -- Ashland Inc. (NYSE: ASH ) today completed its acquisition of Hercules Incorporated, creating a leading specialty chemicals company serving many of the worl...

Labopharm Reports Results for Second Quarter Fiscal 2009

...d quarter of 2010. Corporate Amended Debt Facility Agreement with hercules - Labopharm amended its debt facility agreement with hercules Technology Growth Capital, Inc. (NASDAQ: HTGC ) to provide more favourabl...

Novasys Medical Receives $18.95 Million in Second Tranche of Series D Financing

... and Skyline Ventures. All three participated in the second tranche, with existing investors Alloy Ventures, Delphi Ventures, GBS Venture Partners and hercules Technology Growth Capital. "In this challenging financing environment, we greatly value the continued support of our investors. They underst...

Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results

...ing fees and financial printing costs totaling approximately $1.1 million. In February 2009, Transcept also retired all principal and interest owed to hercules Technology Growth Capital in the amount of $3.4 million. Cash, cash equivalents and marketable securities totaled $81.0 million at March 31, 2009. ...

Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results

... of 2009, Transcept paid financial advisory fees incurred in connection with the merger of $2.0 million and retired in full all remaining debt owed to hercules Technology Growth Capital for $2.7 million. 2009 Guidance Transcept expects full year 2009 research and development expenses to remain consis...

Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008

... of 2007. During the quarter, the Company drew down an additional US$5 million (Cdn$5.8 million) of its existing US$25 million term loan facility with hercules Technology Growth Capital, Inc., bringing the total principal outstanding under the facility to US$20 million. Twelve-Month Period Ended December...

OneMedPlace announces "OneMedForum 2009" finance conference for emerging medtech companies : Second annual event to be held January 13-14, 2009, in San Francisco

...o-sponsors of "OneMedForum 2009" include: AdvaMed MedTech 2009; Dorsey & Whitney LLP (founding sponsor); European Tech Tour Association; hercules Technology Growth Capital; IDA Ireland; Medical Device Manufacturers Association (MDMA); Medtech Development; National Business Incubator Association ...

Labopharm Reports Results for Third Quarter Fiscal 2008

...its existing US$25 million term loan facility with hercules Technology Growth Capital, Inc., bringing the tota...ult in continued annual growth in product sales. hercules Growth Technology Capital Agreement In accordanc...ent related to Labopharm's term loan facility with hercules Technology Growth Capital, Inc. (Hercules), and as...

Baxa Corporation Named Finalist for Third Year as a Best Company to Work For in Colorado

...lloSource Alpine Bank Baxa Corporation Cheyenne Mountain Resort CoBank Education Sales Management Edward Jones GE Johnson Construction Company hercules Industry Mercury Payment Systems Merrick & Company Pinnacol Assurance PriceWaterhouseCoopers LLP Quest Diagnostics Incorporated T-Mobile USA -- ...

Hercules in Medical Technology

Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis

... hercules Trial Aims to Treat Renal Artery Obstructions and ...today announced enrollment of the first patient in hercules (Herculink Elite Cobalt Chromium Renal Stent Trial...g," said Dr. Martinez de Arraras. "The goal of the hercules trial is to evaluate whether renal artery stenting...

MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial

...h 27, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the hercules Market of the Osaka Securities Exchange (Code Number:4875), today announced positive clinical findings from the 12-month core period of a Phase II cli...

Hercules in Medical Products

Hercules 6700B

Description:... Exclusive, 210° Top Rotation provides uncommon bi-directional flexibility, unequalled for general purpose surgery. The hercules 6700B eliminates any conflicts between surgeon and anesthesiologist during head-end procedures, while providing ample leg room for surgeons who prefer...
Company:Skytron

Hercules in Biological News

ISU researcher identifies genetic pathway responsible for much of plant growth

...eroids, you have more growth, and if you have less steroids, you have less growth and the plant is smaller." Now Yin knows that the HERK1 (named for hercules -- the Greek and Roman god who possessed superhuman strength) pathway, induced by BRs, is controlling much of that growth. Yin and his team's findin...

Mystery behind the strongest creature in the world

... The strongest creature in the world, the hercules Beetle, has a colour-changing trick that scientist... could aid design of intelligent materials. The hercules Beetle is remarkable, not only for its strength, a... The sort of structural behaviour displayed by the hercules Beetle could be an important property for intellig...

Science, not romance, controls mating at Smithsonian's National Zoo

...s in North America to have a specialized breeding program for this amphibian. At the Invertebrates exhibit, biologists began studying how to breed hercules beetles in captivity. These insects are most active and ready to breed after dark, but when brought into human care, these beetles often lose their in...

Hercules in Biological Technology

Transformation of Filamentous Fungi by Microprojectile Bombardment

...gh voltage electroporation, Bulletin 1352, Bio-Rad Laboratories, hercules CA (1990). 10. Heiser, W., Optimization of the Biolistic transfor...-driven PDS-1000/He system, Bulletin 1688, Bio-Rad Laboratories, hercules CA (1992). 11. Herzog, R. W., Daniell, H., Singh, N. K. and Lemke...